Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
ContributorsVan Cutsem, Eric; Labianca, Roberto; Bodoky, György; Barone, Carlo; Aranda, Enrique; Nordlinger, Bernard; Topham, Claire; Tabernero, Josep; André, Thierry; Sobrero, Alberto F.; Mini, Enrico; Greil, Richard; Di Costanzo, Francesco; Collette, Laurence; Cisar, Laura; Zhang, Xiaoxi; Khayat, David; Bokemeyer, Carsten; Roth, Arnaud; Cunningham, David
Published inJournal of clinical oncology, vol. 27, no. 19, p. 3117-3125
Publication date2009
Abstract
Keywords
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Camptothecin/administration & dosage/adverse effects/analogs & derivatives
- Chemotherapy, Adjuvant/methods
- Colonic Neoplasms/drug therapy/mortality/pathology
- Disease-Free Survival
- Female
- Fluorouracil/administration & dosage/adverse effects
- Humans
- Infusions, Intravenous
- Kaplan-Meiers Estimate
- Leucovorin/administration & dosage/adverse effects
- Male
- Middle Aged
- Neoplasm Staging
Affiliation
Research group
Citation (ISO format)
VAN CUTSEM, Eric et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. In: Journal of clinical oncology, 2009, vol. 27, n° 19, p. 3117–3125. doi: 10.1200/JCO.2008.21.6663
Main files (1)
Article (Published version)
Identifiers
- PID : unige:5461
- DOI : 10.1200/JCO.2008.21.6663
- PMID : 19451425
Commercial URLhttp://jco.ascopubs.org/cgi/content/full/27/19/3117
ISSN of the journal0732-183X